Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · IEX Real-Time Price · USD
7.82
-0.26 (-3.22%)
At close: Apr 26, 2024, 4:00 PM
8.24
+0.42 (5.37%)
After-hours: Apr 26, 2024, 6:55 PM EDT
Ironwood Pharmaceuticals Employees
Ironwood Pharmaceuticals had 267 employees on December 31, 2023. The number of employees increased by 48 or 21.92% compared to the previous year.
Employees
267
Change (1Y)
48
Growth (1Y)
21.92%
Revenue / Employee
$1,658,184
Profits / Employee
-$3,753,704
Market Cap
1.22B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 267 | 48 | 21.92% |
Dec 31, 2022 | 219 | 0 | - |
Dec 31, 2021 | 219 | -13 | -5.60% |
Dec 31, 2020 | 232 | -85 | -26.81% |
Dec 31, 2019 | 317 | -198 | -38.45% |
Dec 31, 2018 | 515 | -215 | -29.45% |
Dec 31, 2017 | 730 | 56 | 8.31% |
Dec 31, 2016 | 674 | 200 | 42.19% |
Dec 31, 2015 | 474 | 10 | 2.16% |
Dec 31, 2014 | 464 | -70 | -13.11% |
Dec 31, 2013 | 534 | 4 | 0.75% |
Dec 31, 2012 | 530 | 254 | 92.03% |
Dec 31, 2011 | 276 | 59 | 27.19% |
Dec 31, 2010 | 217 | 52 | 31.52% |
Dec 31, 2009 | 165 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Pacira BioSciences | 712 |
Deciphera Pharmaceuticals | 355 |
Kiniksa Pharmaceuticals | 297 |
Xencor | 280 |
4D Molecular Therapeutics | 147 |
Pharvaris | 82 |
Verona Pharma | 79 |
Ligand Pharmaceuticals | 58 |
IRWD News
- 2 days ago - Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call - Business Wire
- 18 days ago - ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 22 days ago - INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 4 weeks ago - Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD) - Business Wire
- 5 weeks ago - IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 5 weeks ago - INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 6 weeks ago - SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 7 weeks ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March - Ironwood Pharmaceuticals (NASDAQ:IRWD), Integra Lifesciences (NASDAQ:IART) - Benzinga